# Seurat Therapeutics, Inc. — Form D

Seurat Therapeutics, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-21. The offering totals $773K, of which $773K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-02-21
- Form: D
- Accession: 0001732115-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $773K
- Amount sold: $773K
- Investors: 5
- Date of first sale: 2018-02-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-306108

## Issuer

- Name: Seurat Therapeutics, Inc.
- CIK: 0001732115
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1452 E. 53RD STREET, CHICAGO, IL, 60615
- Phone: 3122482964

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Richard Kraig | Director | Chicago, IL |
| Martin Sanders | Director | SPRING, TX |
| Yuan Zhang | Director | Seattle, WA |
| Richard Kraig | Executive Officer | Chicago, IL |
| Sharon Lew | Executive Officer | SPRING, TX |
| Martin Sanders | Executive Officer | SPRING, TX |
| Yuan Zhang | Executive Officer | Seattle, WA |

## More

- [CIK 1732115 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1732115&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001732115-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.